The Importance of Recognizing a Locally Advanced Pheochromocytoma

Eugenie S Lim¹, Scott A Akker^{1

2}

Affiliations

¹ Queen Mary University of London, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, EC1M 6BQ, United Kingdom.
² St Bartholomew's Hospital, Barts Health NHS Trust, London, EC1A 7BE, United Kingdom.

Editorial

Eugenie S Lim et al. J Clin Endocrinol Metab. 2021.

. 2021 Aug 18;106(9):e3771-e3772.

doi: 10.1210/clinem/dgab366.

Eugenie S Lim¹, Scott A Akker^{1

2}

¹ Queen Mary University of London, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, EC1M 6BQ, United Kingdom.
² St Bartholomew's Hospital, Barts Health NHS Trust, London, EC1A 7BE, United Kingdom.

No abstract available

Keywords: locally advanced pheochromocytoma; metastatic pheochromocytoma; prognostic factor; recurrence-free survival.

Comment on

Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal.
Moog S, Castinetti F, DoCao C, Amar L, Hadoux J, Lussey-Lepoutre C, Borson-Chazot F, Vezzosi D, Drui D, Laboureau S, Raffin Sanson ML, Lamartina L, Pierre P, Batisse Ligner M, Hescot S, Al Ghuzlan A, Renaudin K, Libé R, Laroche S, Deniziaut G, Gimenez-Roqueplo AP, Jannin A, Leboulleux S, Guerin C, Faron M, Baudin E. Moog S, et al. J Clin Endocrinol Metab. 2021 Aug 18;106(9):2726-2737. doi: 10.1210/clinem/dgab202. J Clin Endocrinol Metab. 2021. PMID: 33782697